Jeffrey W. Smith

机构：Mirati Therapeutics (United States), Scripps Memorial Hospital, Cidara Therapeutics (United States), Bioarray Genetics (United States) · ORCID：0000-0002-8691-3470

发表论文 278 篇 · 总被引 18408 次 · h-index 74

代表论文

• Correcting a Fundamental Flaw in the Paradigm for Antimicrobial Susceptibility Testing (2017 · EBioMedicine · 被引 230)
• Metabolic rewiring in melanoma (2016 · Oncogene · 被引 173)
• Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases (2020 · Journal of Medicinal Chemistry · 被引 121)
• An intrinsic mechanism of secreted protein aging and turnover (2015 · Proceedings of the National Academy of Sciences · 被引 115)
• Proteomic atlas of organ vasculopathies triggered by Staphylococcus aureus sepsis (2019 · Nature Communications · 被引 91)
• Three-Dimensional Structures of Full-Length, Membrane-Embedded Human αIIbβ3 Integrin Complexes (2016 · Biophysical Journal · 被引 75)